Q2 2024 Coloplast A/S Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining Coloplast Interim Financial Statements For H1 2023/'24 Conference Call. (Operator Instructions) I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.
/-&
Thank you very much, operator. Good morning, everybody, and welcome to our Half Year '23/'24 conference call. My name is Kristian Villumsen, I'm the CEO of Coloplast and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We'll start like we usually do, with a short presentation by Anders and myself, and then we will open up for questions.
Please turn to Slide #3. We delivered 8% organic growth and a reported EBIT margin before special items up 27% in the second quarter. Return on invested capital after tax and before special items was 15% reflecting impact from the acquisition of Kerecis. I'm satisfied with our performance. We continue to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |